Enteral Feeding Formulas Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Enteral Feeding Formulas Market, By Product Type

7.1.  Enteral Feeding Formulas Market, By Product Type, 2020-2030

7.1.1.    Standard Formula

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Disease-specific Formula

7.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Enteral Feeding Formulas Market, By Flow Type

8.1.  Enteral Feeding Formulas Market, By Flow Type, 2020-2030

8.1.1.    Intermittent Feeding Flow

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Continuous Feeding Flow

8.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Enteral Feeding Formulas Market, By Stage Type

9.1.  Enteral Feeding Formulas Market, By Stage Type, 2020-2030

9.1.1.    Adults

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Pediatrics

9.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Enteral Feeding Formulas Market, By Indication Type

10.1.        Enteral Feeding Formulas Market, By Indication Type, 2020-2030

10.1.1.  Alzheimer’s

10.1.1.1.      Market Revenue and Forecast (2016-2030)

10.1.2.  Nutrition Deficiency

10.1.2.1.      Market Revenue and Forecast (2016-2030)

10.1.3.  Cancer Care

10.1.3.1.      Market Revenue and Forecast (2016-2030)

10.1.4.  Diabetes

10.1.4.1.      Market Revenue and Forecast (2016-2030)

10.1.5.  Chronic Kidney Diseases

10.1.5.1.      Market Revenue and Forecast (2016-2030)

10.1.6.  Orphan Diseases

10.1.6.1.      Market Revenue and Forecast (2016-2030)

10.1.7.  Dysphagia

10.1.7.1.      Market Revenue and Forecast (2016-2030)

10.1.8.  Pain Management

10.1.8.1.      Market Revenue and Forecast (2016-2030)

10.1.9.  Malabsorption/GI Disorder/Diarrhea

10.1.9.1.      Market Revenue and Forecast (2016-2030)

10.1.10.               Others

10.1.10.1.   Market Revenue and Forecast (2016-2030)

Chapter 11.      Global Enteral Feeding Formulas Market, By End-use Type

11.1.        Enteral Feeding Formulas Market, By End-use, 2020-2030

11.1.1.  Hospitals

11.1.1.1.      Market Revenue and Forecast (2016-2030)

11.1.2.  Home Care

11.1.2.1.      Market Revenue and Forecast (2016-2030)

Chapter 12.      Global Enteral Feeding Formulas  Market, Regional Estimates and Trend Forecast

12.1.        North America

12.1.1.  Market Revenue and Forecast, By Product (2016-2030)

12.1.2.  Market Revenue and Forecast, By Flow (2016-2030)

12.1.3.  Market Revenue and Forecast, By Stage (2016-2030)

12.1.4.  Market Revenue and Forecast, By Indication (2016-2030)

12.1.5.  Market Revenue and Forecast, By End-use (2016-2030)

12.1.6.  U.S.

12.1.6.1.      Market Revenue and Forecast, By Product (2016-2030)

12.1.6.2.      Market Revenue and Forecast, By Flow (2016-2030)

12.1.6.3.      Market Revenue and Forecast, By Stage (2016-2030)

12.1.6.4.      Market Revenue and Forecast, By Indication (2016-2030)

12.1.7.  Market Revenue and Forecast, By End-use (2016-2030)

12.1.8.  Rest of North America

12.1.8.1.      Market Revenue and Forecast, By Product (2016-2030)

12.1.8.2.      Market Revenue and Forecast, By Flow (2016-2030)

12.1.8.3.      Market Revenue and Forecast, By Stage (2016-2030)

12.1.8.4.      Market Revenue and Forecast, By Indication (2016-2030)

12.1.8.5.      Market Revenue and Forecast, By End-use (2016-2030)

12.2.        Europe

12.2.1.  Market Revenue and Forecast, By Product (2016-2030)

12.2.2.  Market Revenue and Forecast, By Flow (2016-2030)

12.2.3.  Market Revenue and Forecast, By Stage (2016-2030)

12.2.4.  Market Revenue and Forecast, By Indication (2016-2030)

12.2.5.  Market Revenue and Forecast, By End-use (2016-2030)

12.2.6.  UK

12.2.6.1.      Market Revenue and Forecast, By Product (2016-2030)

12.2.6.2.      Market Revenue and Forecast, By Flow (2016-2030)

12.2.6.3.      Market Revenue and Forecast, By Stage (2016-2030)

12.2.7.  Market Revenue and Forecast, By Indication (2016-2030)

12.2.8.  Market Revenue and Forecast, By End-use (2016-2030)

12.2.9.  Germany

12.2.9.1.      Market Revenue and Forecast, By Product (2016-2030)

12.2.9.2.      Market Revenue and Forecast, By Flow (2016-2030)

12.2.9.3.      Market Revenue and Forecast, By Stage (2016-2030)

12.2.10.               Market Revenue and Forecast, By Indication (2016-2030)

12.2.11.               Market Revenue and Forecast, By End-use (2016-2030)

12.2.12.               France

12.2.12.1.   Market Revenue and Forecast, By Product (2016-2030)

12.2.12.2.   Market Revenue and Forecast, By Flow (2016-2030)

12.2.12.3.   Market Revenue and Forecast, By Stage (2016-2030)

12.2.12.4.   Market Revenue and Forecast, By Indication (2016-2030)

12.2.13.               Market Revenue and Forecast, By End-use (2016-2030)

12.2.14.               Rest of Europe

12.2.14.1.   Market Revenue and Forecast, By Product (2016-2030)

12.2.14.2.   Market Revenue and Forecast, By Flow (2016-2030)

12.2.14.3.   Market Revenue and Forecast, By Stage (2016-2030)

12.2.14.4.   Market Revenue and Forecast, By Indication (2016-2030)

12.2.15.               Market Revenue and Forecast, By End-use (2016-2030)

12.3.        APAC

12.3.1.  Market Revenue and Forecast, By Product (2016-2030)

12.3.2.  Market Revenue and Forecast, By Flow (2016-2030)

12.3.3.  Market Revenue and Forecast, By Stage (2016-2030)

12.3.4.  Market Revenue and Forecast, By Indication (2016-2030)

12.3.5.  Market Revenue and Forecast, By End-use (2016-2030)

12.3.6.  India

12.3.6.1.      Market Revenue and Forecast, By Product (2016-2030)

12.3.6.2.      Market Revenue and Forecast, By Flow (2016-2030)

12.3.6.3.      Market Revenue and Forecast, By Stage (2016-2030)

12.3.6.4.      Market Revenue and Forecast, By Indication (2016-2030)

12.3.7.  Market Revenue and Forecast, By End-use (2016-2030)

12.3.8.  China

12.3.8.1.      Market Revenue and Forecast, By Product (2016-2030)

12.3.8.2.      Market Revenue and Forecast, By Flow (2016-2030)

12.3.8.3.      Market Revenue and Forecast, By Stage (2016-2030)

12.3.8.4.      Market Revenue and Forecast, By Indication (2016-2030)

12.3.9.  Market Revenue and Forecast, By End-use (2016-2030)

12.3.10.               Japan

12.3.10.1.   Market Revenue and Forecast, By Product (2016-2030)

12.3.10.2.   Market Revenue and Forecast, By Flow (2016-2030)

12.3.10.3.   Market Revenue and Forecast, By Stage (2016-2030)

12.3.10.4.   Market Revenue and Forecast, By Indication (2016-2030)

12.3.10.5.   Market Revenue and Forecast, By End-use (2016-2030)

12.3.11.               Rest of APAC

12.3.11.1.   Market Revenue and Forecast, By Product (2016-2030)

12.3.11.2.   Market Revenue and Forecast, By Flow (2016-2030)

12.3.11.3.   Market Revenue and Forecast, By Stage (2016-2030)

12.3.11.4.   Market Revenue and Forecast, By Indication (2016-2030)

12.3.11.5.   Market Revenue and Forecast, By End-use (2016-2030)

12.4.        MEA

12.4.1.  Market Revenue and Forecast, By Product (2016-2030)

12.4.2.  Market Revenue and Forecast, By Flow (2016-2030)

12.4.3.  Market Revenue and Forecast, By Stage (2016-2030)

12.4.4.  Market Revenue and Forecast, By Indication (2016-2030)

12.4.5.  Market Revenue and Forecast, By End-use (2016-2030)

12.4.6.  GCC

12.4.6.1.      Market Revenue and Forecast, By Product (2016-2030)

12.4.6.2.      Market Revenue and Forecast, By Flow (2016-2030)

12.4.6.3.      Market Revenue and Forecast, By Stage (2016-2030)

12.4.6.4.      Market Revenue and Forecast, By Indication (2016-2030)

12.4.7.  Market Revenue and Forecast, By End-use (2016-2030)

12.4.8.  North Africa

12.4.8.1.      Market Revenue and Forecast, By Product (2016-2030)

12.4.8.2.      Market Revenue and Forecast, By Flow (2016-2030)

12.4.8.3.      Market Revenue and Forecast, By Stage (2016-2030)

12.4.8.4.      Market Revenue and Forecast, By Indication (2016-2030)

12.4.9.  Market Revenue and Forecast, By End-use (2016-2030)

12.4.10.               South Africa

12.4.10.1.   Market Revenue and Forecast, By Product (2016-2030)

12.4.10.2.   Market Revenue and Forecast, By Flow (2016-2030)

12.4.10.3.   Market Revenue and Forecast, By Stage (2016-2030)

12.4.10.4.   Market Revenue and Forecast, By Indication (2016-2030)

12.4.10.5.   Market Revenue and Forecast, By End-use (2016-2030)

12.4.11.               Rest of MEA

12.4.11.1.   Market Revenue and Forecast, By Product (2016-2030)

12.4.11.2.   Market Revenue and Forecast, By Flow (2016-2030)

12.4.11.3.   Market Revenue and Forecast, By Stage (2016-2030)

12.4.11.4.   Market Revenue and Forecast, By Indication (2016-2030)

12.4.11.5.   Market Revenue and Forecast, By End-use (2016-2030)

12.5.        Latin America

12.5.1.  Market Revenue and Forecast, By Product (2016-2030)

12.5.2.  Market Revenue and Forecast, By Flow (2016-2030)

12.5.3.  Market Revenue and Forecast, By Stage (2016-2030)

12.5.4.  Market Revenue and Forecast, By Indication (2016-2030)

12.5.5.  Market Revenue and Forecast, By End-use (2016-2030)

12.5.6.  Brazil

12.5.6.1.      Market Revenue and Forecast, By Product (2016-2030)

12.5.6.2.      Market Revenue and Forecast, By Flow (2016-2030)

12.5.6.3.      Market Revenue and Forecast, By Stage (2016-2030)

12.5.6.4.      Market Revenue and Forecast, By Indication (2016-2030)

12.5.7.  Market Revenue and Forecast, By End-use (2016-2030)

12.5.8.  Rest of LATAM

12.5.8.1.      Market Revenue and Forecast, By Product (2016-2030)

12.5.8.2.      Market Revenue and Forecast, By Flow (2016-2030)

12.5.8.3.      Market Revenue and Forecast, By Stage (2016-2030)

12.5.8.4.      Market Revenue and Forecast, By Indication (2016-2030)

12.5.8.5.      Market Revenue and Forecast, By End-use (2016-2030)

Chapter 13.  Company Profiles

13.1.              Danone (Nutricia)

13.1.1.  Company Overview

13.1.2.  Product Offerings

13.1.3.  Financial Performance

13.1.4.  Recent Initiatives

13.2.              Nestle Health Science

13.2.1.  Company Overview

13.2.2.  Product Offerings

13.2.3.  Financial Performance

13.2.4.  Recent Initiatives

13.3.              Abbott Nutrition

13.3.1.  Company Overview

13.3.2.  Product Offerings

13.3.3.  Financial Performance

13.3.4.  Recent Initiatives

13.4.              Primus Pharmaceuticals, Inc.

13.4.1.  Company Overview

13.4.2.  Product Offerings

13.4.3.  Financial Performance

13.4.4.  Recent Initiatives

13.5.              Mead Johnson & Company, LLC

13.5.1.  Company Overview

13.5.2.  Product Offerings

13.5.3.  Financial Performance

13.5.4.  Recent Initiatives

13.6.              Fresenius Kabi AG

13.6.1.  Company Overview

13.6.2.  Product Offerings

13.6.3.  Financial Performance

13.6.4.  Recent Initiatives

13.7.              Meiji Holdings Co., Ltd.

13.7.1.  Company Overview

13.7.2.  Product Offerings

13.7.3.  Financial Performance

13.7.4.  Recent Initiatives

13.8.              Victus

13.8.1.  Company Overview

13.8.2.  Product Offerings

13.8.3.  Financial Performance

13.8.4.  Recent Initiatives

Chapter 14.  Research Methodology

14.1.              Primary Research

14.2.              Secondary Research

14.3.              Assumptions

Chapter 15.  Appendix

15.1.              About Us

Glossary of Terms

Report Details

  • Report Code:37531
  • Category:Healthcare
  • No. of Pages:250
  • Format:PDF/PPT/Excel
  • Published:March 2021
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers